States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some ...

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.

The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain ...

Hims & Hers Health said it is expanding its weight-loss offerings with the addition of Eli Lilly & Co.'s Zepbound and generic liraglutide. The telehealth-consultation platform on Tuesday said it aimed ...

"We had seen potential for CagriSema to demonstrate superior weight loss to Zepbound given the amylin component; however, the CagriSema delta from obese to obese diabetics patients looks very ...

Amanda Halterman is working on her self-confidence amid her weight loss journey. On March 15, the 1000-Lb. Sisters star and older sister of Tammy and Amy Slaton posted a photo on Instagram ...

The days of cheaper alternatives to popular weight-loss drugs like Wegovy and Zepbound are over for some Long Islanders and are numbered for others, pharmacists and compounding industry groups say.

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide ... tirzepatide achieved at least 25% body weight loss compared to 16.1% of those receiving ...

This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro. Online, it doesn't look like much ...

Society is obsessive about weight loss, whether it’s online comments speculating about an influencer’s weight gain or tabloids questioning if a celebrity has become too small for their own good.